BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14688442)

  • 1. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
    Wenger T; Ledent C; Tramu G
    Neuroendocrinology; 2003 Dec; 78(6):294-300. PubMed ID: 14688442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus.
    Wenger T; Jamali KA; Juanéda C; Léonardelli J; Tramu G
    Biochem Biophys Res Commun; 1997 Aug; 237(3):724-8. PubMed ID: 9299434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice.
    Barna I; Zelena D; Arszovszki AC; Ledent C
    Life Sci; 2004 Oct; 75(24):2959-70. PubMed ID: 15454346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.
    Patel S; Roelke CT; Rademacher DJ; Cullinan WE; Hillard CJ
    Endocrinology; 2004 Dec; 145(12):5431-8. PubMed ID: 15331569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic.
    Atkinson HC; Leggett JD; Wood SA; Castrique ES; Kershaw YM; Lightman SL
    Endocrinology; 2010 Aug; 151(8):3720-7. PubMed ID: 20534730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
    Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB
    Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.
    Hill MN; Ho WS; Sinopoli KJ; Viau V; Hillard CJ; Gorzalka BB
    Neuropsychopharmacology; 2006 Dec; 31(12):2591-9. PubMed ID: 16710317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.
    Cota D; Steiner MA; Marsicano G; Cervino C; Herman JP; Grübler Y; Stalla J; Pasquali R; Lutz B; Stalla GK; Pagotto U
    Endocrinology; 2007 Apr; 148(4):1574-81. PubMed ID: 17194743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.
    Newsom RJ; Osterlund C; Masini CV; Day HE; Spencer RL; Campeau S
    Neuroscience; 2012 Mar; 204():64-73. PubMed ID: 22138156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents.
    Wade MR; Degroot A; Nomikos GG
    Eur J Pharmacol; 2006 Dec; 551(1-3):162-7. PubMed ID: 17030030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG.
    Oláh M; Milloh H; Wenger T
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S36-40. PubMed ID: 18308464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress.
    Surkin PN; Gallino SL; Luce V; Correa F; Fernandez-Solari J; De Laurentiis A
    Psychoneuroendocrinology; 2018 Jan; 87():131-140. PubMed ID: 29065362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress.
    Rabasa C; Pastor-Ciurana J; Delgado-Morales R; Gómez-Román A; Carrasco J; Gagliano H; García-Gutiérrez MS; Manzanares J; Armario A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1248-59. PubMed ID: 26092203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation.
    Newsom RJ; Garcia RJ; Stafford J; Osterlund C; O'Neill CE; Day HEW; Campeau S
    Psychoneuroendocrinology; 2020 Mar; 113():104549. PubMed ID: 31884322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis.
    Mikkelsen JD; Søderman A; Kiss A; Mirza N
    Eur J Pharmacol; 2005 Sep; 519(3):223-30. PubMed ID: 16125698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
    Ginsberg AB; Pecoraro NC; Warne JP; Horneman HF; Dallman MF
    Stress; 2010 May; 13(3):248-57. PubMed ID: 20392196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
    Zelena D; Mergl Z; Makara GB
    Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion.
    Ruginsk SG; Uchoa ET; Elias LL; Antunes-Rodrigues J
    Clin Exp Pharmacol Physiol; 2013 Oct; 40(10):698-705. PubMed ID: 23875874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis.
    Dhillo WS; Small CJ; Jethwa PH; Russell SH; Gardiner JV; Bewick GA; Seth A; Murphy KG; Ghatei MA; Bloom SR
    Endocrinology; 2003 Apr; 144(4):1420-5. PubMed ID: 12639925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.